Cipla launches Cipremi, likely to price it Rs 4,000 per vial EP News Bureau Jul 9, 2020 It is looking to supply over 80,000 vials within the first month
Premas Biotech initiates triple antigen VLP COVID-19 vaccine candidate for animal trials EP News Bureau Jul 9, 2020 At the moment, it is the only one from India to adopt a triple-antigen approach that is designed to produce an enhanced immune…
Pharma firms initiate steps to curb black marketing of remedisivir Usha Sharma Jul 8, 2020 Measures include constant monitoring of the drug’s usage and ensuring its uninterrupted supply by working in collaboration with…
Blueprint for self-reliance in the bio-pharma sector EP News Bureau Jul 8, 2020 Gaurav Kaushik, MD & CEO, Meteoric Biopharmaceuticals highlights that the COVID-19 crisis has opened a window of opportunity…
Doctors view ‘antiviral agents’ as the most effective therapeutic option for treating COVID-19:… EP News Bureau Jul 8, 2020 Anti-inflammatory drugs, convalescent plasma therapy are opined to be the next-best treatments; AI, ML, Big Data and IoT emerge as…
China’s Sinovac starts late stage trials for its COVID-19 vaccine Reuters Jul 8, 2020 Moderna also plans to start its late-stage trial this month
Serum Institute of India expects COVID vaccine by year-end Press Trust of India Jul 8, 2020 He was speaking during the launch of 'Compact XL, a compact diagnostics machine by MyLab Discovery Solutions, that will automate…
WHO acknowledges ‘evidence emerging’ of airborne spread of COVID-19 Reuters Jul 8, 2020 The WHO has previously said the virus that causes the COVID-19 respiratory disease spreads primarily through small droplets…
CSIR seeks regulatory nod for clinical trials using combination of antivirals and HDTs against… Press Information Bureau Jul 8, 2020 In collaboration with Laxai Life Sciences, it aims to determine the safety and efficacy of three combination drugs…
‘At war time speed’, China leads COVID-19 vaccine race Reuters Jul 8, 2020 Sinovac Biotech’s experimental vaccine set to become the country’s second and the world’s third to enter final stage testing later…